Pediatric Inflammatory Bowel Diseases: Should We Be Looking for Kidney Abnormalities?

Area of Science:

• Pediatric Nephrology
• Gastroenterology
• Inflammatory Bowel Disease Research

Background:

• Kidney disease is a known complication in adults with inflammatory bowel disease (IBD), presenting as an extraintestinal manifestation or treatment side effect.
• The prevalence and characteristics of kidney pathology in pediatric IBD populations require further elucidation.

Purpose of the Study:

• To investigate the extent of kidney pathology in a cohort of children diagnosed with IBD.
• To identify potential correlations between kidney disease markers, kidney size, and IBD treatment modalities.

Main Methods:

• A cross-sectional study involving 56 children with IBD.
• Analysis of blood and urine samples for kidney disease markers.
• Kidney size assessment using ultrasonography (pole-to-pole length).

Main Results:

• Twenty-five percent of pediatric IBD patients exhibited pre-existing kidney disease or ultrasonographic evidence of chronic kidney disease.
• A statistically significant reduction in median kidney size was observed compared to healthy children.
• Multivariate analysis revealed that infliximab use correlated with smaller kidney size, while enteral nutritional therapy was associated with larger kidneys.

Conclusions:

• Children with IBD are susceptible to developing chronic kidney disease.
• Increased disease severity in pediatric IBD appears to elevate the risk of kidney complications.